- Global Pharma News & Resources

Wound Debridement Products Market is expected to grow at a CAGR of 5.6% between 2022 and 2032

[Report of 250 Pages] In 2022, the market for products for wound debridement is anticipated to be worth US$ 497.3 billion. The overall demand for wound debridement products is anticipated to increase at a CAGR of 5.6% between 2022 and 2032, reaching approximately US$ 857.55 Billion by 2032 due to the rise in the incidence of hard and heal wounds, as well as the rising number of collaborations, partnerships, and new product launches.

Demand for wound debridement products is surging steadily owing to its steady demand, especially from hospitals and specialty clinics. The new edition of the report from Future Market Insights (2021-2031) offers a post COVID-19 analysis on wound debridement sales across the globe. The report also expands on the previous competitive section, with divestures, mergers & acquisitions, and new forays analyzed.

According to latest analysis, wound debridement product sales have witnessed a minor decline in US, the largest market globally. However, demand still continues to be strong and manufacturers can expect a steady stream of opportunities during the forecast period. US currently accounts for nearly one-fourth of all wound debridement sales globally.

The study also finds that manufacturers are focusing on launching innovative products to consolidate their market share.

Get Latest Sample Copy@

Key Takeaways from Study

  • Hospitals will remain the largest demand generators for wound debridement products
  • Strong demand in US to continue in 2021 and beyond, making North America the largest market globally
  • New product innovation to be a key focus area for manufacturers
  • Demand for wound debridement products rising in Asia Pacific as various economies make an early recovery from COVID-19 pandemic

Wound Debridement Products Market – Report Scope

Attribute Details
Forecast Period 2021-2031
Historical Data Available for 2016-2024
Market Analysis USD Million for Value
Key Regions Covered North America, Latin America, Europe, Asia Pacific, MEA
Key Segments Covered End users, Regions, Applications, Product types
Key Companies Profiled
  • Smith & Nephew PLC
  • Derma Sciences, Inc.
  • Lohmann & Rauscher International
  • Zimmer Biomet
  • DeRoyal Industries Inc.
  • Arobella Medical
  • LLC, Misonix
  • Söring GmbH
  • BSN Medical
  • Molnlycke Healthcare AB.
Report Coverage Market Forecasts, Brand Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Ask from Market Research Expert –

Applications in Treating Chronic Ulcers and Surgical Wounds Driving Demand

Demand for wound debridement products continues to remain high for treating chronic ulcers and surgical wounds. According to the study, these two application areas continue to create opportunities for market players. Of particular significant is application in chronic leg ulcers. Chronic ulceration of lower legs continues to be a challenge area, with 3.6% of people older than 65 years suffering from this (Grant Medical College).

FMI’s study reveals that use of wound debridement products in treating these types of ulcers will continue to account for steady demand over the course of the forecast period.

Demand Likely to Increase in Asia Pacific

FMI’s analysis reveals US to be the most lucrative market for wound debridement products, but owing to relatively less impact on many Asian economies, demand is likely to surge.

China, India, and South East Asian countries have been lesser impacted by the covid-19 crisis, as compared to US and Western Europe. Further, healthcare sector in these countries is going through an infrastructure revamp, which is also likely to create opportunities for manufacturers.

Wound Debridement Products Market – Competitive Analysis

Manufacturers are focusing on the developing innovative wound debridement products to consolidate their positon in the market. These products are able to cure the wounds, prevent bacterial infections and accelerate the healing time.  According to FMI, the key strategy being followed by the leading companies in the industry is the product portfolio expansion.

For instance, Axio Biosolutions, a leading Indian company working in the industry, is consistently working on the creation of an emergency wound hemostat. The company also launched an effective dressing namely “Axiostat” which gained a whole lot of importance and wide acceptance across the defense forces and civil hospitals. The dressing has helped majorly in preventing bleeding in the wounds.

A US based company namely, Organogenesis, manufactured “Purple”, a product that prevents the microbial growth in the wounds and also enables quick recovery. Various other players in the market have been continuously working to develop and manufacture products that get a high rate of profit.

Segmentation by Category

End Users

  • Hospitals
  • Ambulatory Surgical Centres
  • Specialised Clinics
  • Nursing Facilities
  • Others

For in-depth insights, Download a PDF Brochure –


  • Chronic Ulcers
  • Surgical Wounds
  • Traumatic Wounds
  • Burn Cases

Product Types

  • Hydrosurgical Debridement Devices
  • Low Frequency Ultrasound Devices
  • Surgical Wound Debridement Devices
  • Mechanical Debridement Pads
  • Traditional Wound Debridement Devices
  • Larval Therapy

About FMI:

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
LinkedIn| Twitter| Blogs

Editor Details

Last Updated: 02-May-2023